1368P TALAPRO-1: Talazoparib Monotherapy in Metastatic Castration-Resistant Prostate Cancer (mcrpc) with DNA Damage Response Alterations (ddrm) – Exploration of Tumor Genetics Associated with Prolonged Benefit
Annals of Oncology(2022)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined